NuVasive Announces New Organizational Structure to Align Global Commercial Operations and Product & Services Organization with Long-Term StrategyPRNewsWire • 10/14/20
NuVasive Expands Precice Portfolio with First-of-its-Kind Plate for Pediatric Limb Lengthening and Reconstruction ProceduresPRNewsWire • 09/09/20
NuVasive, Inc. (NUVA) CEO Chris Barry on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/05/20
Will NuVasive (NUVA) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 07/29/20
Beyond COVID-19, Credit Suisse Shows Its Top Health Care Recovery Stock Picks24/7 Wall Street • 07/28/20
NuVasive (NUVA) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 07/28/20
Nuvasive Shows Improved Relative Price Performance; Still Shy Of BenchmarkInvestors Business Daily • 06/15/20
NuVasive (NUVA) Up 6.6% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/05/20
NuVasive, Inc. Announces Full Exercise Of Option By Initial Purchasers To Purchase Additional 1.00% Convertible Senior Notes Due 2023PRNewsWire • 06/04/20
NuVasive, Inc. Announces Pricing Of Offering Of $400 Million Of 1.00% Convertible Senior Notes Due 2023PRNewsWire • 05/28/20
NuVasive, Inc. Announces Proposed Offering Of $400 Million Of Convertible Senior Notes Due 2023PRNewsWire • 05/26/20